Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Endogenous Metabolite
    (2)
  • 5-HT Receptor
    (1)
  • AChR
    (1)
  • Apelin receptor
    (1)
  • Bcl-2 Family
    (1)
  • CGRP Receptor
    (1)
  • Dopamine Receptor
    (1)
  • Ephrin Receptor
    (1)
  • Histamine Receptor
    (1)
  • Others
    (17)
Filter
Search Result
Results for "

colonic

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    32
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    4
    TargetMol | Peptide_Products
  • Natural Products
    7
    TargetMol | Natural_Products
  • Recombinant Protein
    13
    TargetMol | Recombinant_Protein
  • Isotope Products
    1
    TargetMol | Isotope_Products
Trimebutine
Mebutin
T091839133-31-8
Trimebutine (Mebutin) is a spasmolytic agent that regulates intestinal and colonic motility and relieves abdominal pain with antimuscarinic and weak mu-opioid agonist effects. It is marketed for the treatment of irritable bowel syndrome (IBS) and lower gastrointestinal tract motility disorders, with IBS being one of the most common multifactorial GI disorders. It is used to restore normal bowel function and is commonly present in pharmaceutical mixtures as trimebutine maleate salt form. Trimebutine is not an FDA-Approved Clinical drug, but it is available in Canada and several other international countries.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Glycoursodeoxycholic acid
Ursodeoxycholylglycine, GUDCA
T523464480-66-6
Glycoursodeoxycholic acid (Ursodeoxycholylglycine) is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct, therefore, exist in a glycine conjugated form. Bile acids are steroid acids found predominantly in bile of mammals.
  • Inquiry Price
Size
QTY
Glycodeoxycholate Sodium
Sodium glycyldeoxycholate, Sodium glycodeoxycholate, Glycodeoxycholic acid sodium salt
T525416409-34-0
The mechanism by which Glycodeoxycholate Sodium induces apoptosis in hepatocytes is related to DNA cleavage by endonucleases. It is a secondary bile acid produced by the action of enzymes present in the microflora of the colonic environment.
  • Inquiry Price
Size
QTY
TargetMol
A-1211212
BCL2-IN-1
T104841257044-75-9
A-1211212 (BCL2-IN-1) is a potent and selective Bcl-2 inhibitor. It promotes lymphocyte apoptosis, alters colonic mucosa in mice, and improves inflammation.
  • Inquiry Price
Size
QTY
Zamifenacin fumarate
UK-76654 fumarate
T13385127308-98-9
Zamifenacin fumarate (UK-76654 fumarate) is a potent, gut-selective antagonist of the muscarinic M3 receptor.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
Lafutidine
FRG-8813
T0081118288-08-7
Lafutidine (FRG-8813) is a newly developed histamine H2-receptor antagonist that inhibits gastric acid secretion.
  • Inquiry Price
Size
QTY
Zamifenacin
UK-76654
T17283127308-82-1
Zamifenacin obviously decreases colonic motility in irritable bowel syndrome. Zamifenacin is an effective gut-selective muscarinic M3 receptor antagonist.
  • Inquiry Price
1-2 weeks
Size
QTY
X-17
T203246
X-17 is a potent Vanin-1 inhibitor known for its anti-inflammatory and antioxidant properties. It reduces the expression of inflammatory factors and inhibits myeloperoxidase activity, while enhancing colonic glutathione reserves and restoring the intestinal barrier.
  • Inquiry Price
Size
QTY
SKF38393 hydrobromide
SKF 38393 hydrobromide
T2335920012-10-6
SKF38393 hydrobromide is the salt form of SKF38393.SKF38393 is a dopamine D1 receptor agonist that increases the expression of Shati Nat8L mRNA in the NAc of mice; increases the frequency of 5-hydroxytryptamine and n -methyl- D -aspartate-induced locomotion-associated ruptures in astrocytes; can mimic the dopamine-induced inhibition of colonic motility in mice; can promote locust swarming
  • Inquiry Price
1-2 weeks
Size
QTY
Aloe emodin anthrone
T298876247-99-0
Aloe emodin anthrone is a stimulant-laxative which has been shown to enhance colonic membrane permeability of water-soluble and poorly permeable compounds.
  • Inquiry Price
Size
QTY
Aloe-emodin-glucoside
T2988829010-56-8
Aloe-emodin-glucoside is a stimulant-laxative which has been shown to enhance colonic membrane permeability of water-soluble and poorly permeable compounds.
  • Inquiry Price
Size
QTY
Butyrylcholine
BA 51 090059,BA-51-090059,BA 51090059,BA 51-090059
T306403922-86-9
Butyrylcholine is a novel colonic ion transport regulator produced by colonic epithelial cells that stimulates nicotine and muscarinic receptors.
  • Inquiry Price
6-8 weeks
Size
QTY
MK-8970
T33443
MK-8970 is an acetal carbonate prodrug of raltegravir with enhanced colonic absorption.
  • Inquiry Price
Size
QTY
STA 2
STA-2, STA2, ONO 11113
T3471089617-02-7
STA 2 is an analogue of TXA2, a thromboxane receptor in the colonic epithelium.
  • Inquiry Price
10-14 weeks
Size
QTY
(Ala13)-Apelin-13 acetate
T35374L
(Ala13)-Apelin-13 acetate, an APJ antagonist, modulates CRF-induced enhanced colonic motility, visceral sensation, and gut barrier.
  • Inquiry Price
Size
QTY
Urocortin II (mouse) (trifluoroacetate salt)
T36373
Urocortin II is a neuropeptide hormone and member of the corticotropin-releasing factor (CRF) family which includes mammalian CRF , urocortin , urocortin III , frog sauvagine, and piscine urotensin I.1 Mouse urocortin II shares 34 and 42% sequence homology with rat CRF and urocortin . It is expressed in mouse paraventricular, supraoptic, and arcuate nuclei of the hypothalamus, the locus coeruleus, and in motor nuclei of the brainstem and spinal ventral horn. Urocortin II selectively binds to CRF1 over CRF2 receptors (Kis = 0.66 and >100 nM, respectively) and induces cAMP production in CHO cells expressing CRF2 (EC50 = 0.14 nM). In vivo, urocortin II suppresses nighttime food intake by 35% in rats when administered intracerebroventricularly at a dose of 1 μg. Urocortin II (0.1 and 0.5 μg, i.c.v) stimulates fecal pellet output, increases distal colonic transit, and inhibits gastric emptying in mice.2References1. Reyes, T.M., Lewis, K., Perrin, M.H., et al. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U.S.A. 98(5), 2843-2848 (2001).2. Martinez, V., Wang, L., Million, M., et al. Urocortins and the regulation of gastrointestinal motor function and visceral pain. Peptides 25(10), 1733-1744 (2004). Urocortin II is a neuropeptide hormone and member of the corticotropin-releasing factor (CRF) family which includes mammalian CRF , urocortin , urocortin III , frog sauvagine, and piscine urotensin I.1 Mouse urocortin II shares 34 and 42% sequence homology with rat CRF and urocortin . It is expressed in mouse paraventricular, supraoptic, and arcuate nuclei of the hypothalamus, the locus coeruleus, and in motor nuclei of the brainstem and spinal ventral horn. Urocortin II selectively binds to CRF1 over CRF2 receptors (Kis = 0.66 and >100 nM, respectively) and induces cAMP production in CHO cells expressing CRF2 (EC50 = 0.14 nM). In vivo, urocortin II suppresses nighttime food intake by 35% in rats when administered intracerebroventricularly at a dose of 1 μg. Urocortin II (0.1 and 0.5 μg, i.c.v) stimulates fecal pellet output, increases distal colonic transit, and inhibits gastric emptying in mice.2 References1. Reyes, T.M., Lewis, K., Perrin, M.H., et al. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U.S.A. 98(5), 2843-2848 (2001).2. Martinez, V., Wang, L., Million, M., et al. Urocortins and the regulation of gastrointestinal motor function and visceral pain. Peptides 25(10), 1733-1744 (2004).
  • Inquiry Price
Size
QTY
Theaflavin digallate
Theaflavine bisgallate, theaflavin digallate, TFBG
T4S055433377-72-9
Theaflavin digallate and lactic acid together could reduce herpes simplex virus transmission.
  • Inquiry Price
Size
QTY
Succinic acid sodium
T6429414047-56-4
Succinic acid sodium is an orally active anxiolytic. Succinic acid sodium down-regulates the expression of KCNMB1 (potassium channel subunit β1) and TET1 (10-11 translocation 1). succinic acid sodium inhibits the proliferation of colonic epithelial cells in vivo. Succinic acid sodium can be used to study hypertension in pregnancy.
  • Inquiry Price
1-2 weeks
Size
QTY
(6S)-N-Benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxohexahydro-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide
T65994868774-16-7
Wnt signaling is required for direct multiple biological processes and also plays key roles in the pathogenesis of various diseases. Cyclic AMP response element-binding protein (CREB) is a transcription factor that is a member of the leucine zipper family of DNA binding proteins. This protein binds as a homodimer to the cAMP-responsive element, an octameric palindrome. The protein is phosphorylated by several protein kinases, and induces transcription of genes in response to hormonal stimulation of the cAMP pathway. Via generating a transcriptionally active complex with β-catenin, CREB acts as a mediator of Wnt signaling.ICG-001 is an inhibitor of β-catenin CREB mediated transcription. The direct cellular target of ICG-001 is CREB. the inhibitory IC50of ICG-001 against β-catenin CREB mediated transcription was 3 μM. ICG-001 treatment at the concentration of 25 μM for 24h significantly increased caspase activity in both colon cancer cell lines SW480 and HCT116 cell lines but not in normal colonic epithelial cells CCD-841Co. In a cell growth inhibition assay, the IC50s of ICG-001 against SW480 and HCT116 cells were 4.43 μM and 5.95 μM, respectively.In a SW620 nude mouse xenograft model, an water-soluble analog of ICG-001 given at the dose of 150 mg kg i.v. once in every 2 days dramatically suppressed tumor growth. In a bleomycin-induced pulmonary fibrosis mice model, ICG-001 given at the dose of 5 mg kg per day reversed pulmonary fibrosis. In a rat myocardial infarction model, ICG-001 was administrated subcutaneously at the dose of 50 mg kg day for 10 days which significantly improved cardiac contractile function after myocardial infarction in the rats.
    7-10 days
    Inquiry
    Ciclotropium (free base)
    T68735764602-65-5
    Ciclotropium (free base) is quaternary ammonium compound with anticholinergic and parasympatholytic activity. Oral Cyclotropium bromide inhibited fasting and meal-stimulated colonic motility significantly without causing adverse side effects. After cyclotropium bromide, there was a significant correlation between antral contraction amplitude and gastric emptying.
    • Inquiry Price
    6-8 weeks
    Size
    QTY
    DRAinh-A250
    T71738858747-13-4
    DRAinh-A250 is a SLC26A3 inhibitor which blocks colonic fluid absorption and reduces constipation.
    • Inquiry Price
    6-8 weeks
    Size
    QTY
    Urolithin D
    T74005131086-98-1
    Urolithin D is a competitive and selective reversible antagonist of the EphA receptor, an ellagitannin colonic metabolite that inhibits EphA2 phosphorylation in prostate cancer cells, attenuates triglyceride accumulation in adipocytes and hepatocyte cultures, and may be used in the study of metabolic disorders.
    • Inquiry Price
    Size
    QTY
    Urocortin III (mouse) (free acid)
    T76319
    Urocortin III (mouse) (free acid), a selective high-affinity agonist for the CRF2 receptor, significantly inhibits gastric emptying without affecting colonic transit [1] [2].
    • Inquiry Price
    Size
    QTY
    α-CGRP (mouse, rat) TFA
    T78540
    α-CGRP (mouse, rat) TFA, a neuropeptide belonging to the calcitonin gene-related peptide (CGRP) family, is predominantly located at neuromuscular junctions and functions as a potent vasodilator. Peripheral administration of α-CGRP (mouse, rat) TFA may result in decreased blood pressure and elevated heart rate, in addition to the relaxation of colonic smooth muscle. This compound shows promising utility in the investigation of cardiovascular, pro-inflammatory, migraine, and metabolic conditions [1] [2] [3].
    • Inquiry Price
    Size
    QTY